LALEIatlas

LEI record

· Cyprus

A - EEA & CIS PHARMA VENTURES

LapsedActive
2549
00
LQDYQL5XFOQD
73
Issuer (LOU)
Res.
Entity identifier
Check
Legal form
Sub-fund
Jurisdiction
Cyprus
Registered
16 Apr 2020
Next renewal
16 Mar 2025

Reference data

Identity

LEI
254900LQDYQL5XFOQD73
Legal form
Sub-fund8888
Registration authority
RA000162entity ID AIF39_1
Legal address
Vyzantiou, 15, 1st Floor, Office 101, Chryseleousa, Strovolos, NICOSIA, 2064, CY
HQ address
C/O BYRON CAPITAL PARTNERS LTD, 113 PRODROMOU AVENUE, OFFICE 201, STROVOLOS, NICOSIA, CY
Initial registration
16 Apr 2020
Last updated
17 Mar 2025
Managing LOU (issuer)
Bloomberg Finance L.P.5493001KJTIIGC8Y1R12

Level 2 · who owns whom

Corporate structure

Direct accounting consolidation parent: Non consolidating
Ultimate accounting consolidation parent: Non consolidating

Securities & codes

Securities and identifiers

No securities, bank or market codes mapped to this entity.

The archive · 1 version

Change history

First recorded in this archive on 6 Jul 2026. Future changes to name, status, address, ownership or renewal date will appear here.

What this means

Plain-language summary

The LEI is a 20-character ISO 17442 code identifying this legal entity in financial transactions. Its legal form is “Sub-fund”. It is registered in Cyprus.

Its LEI has been on record for 6 years, since 2020. Its annual renewal is overdue — it was due 16 Mar 2025.

Lapsed is the status of the LEI registration; the entity status (Active) describes whether the legal entity itself still exists.

The mesh

Related entities

Source: GLEIF (CC0)Official record ↗More in Cyprus